Lyle Arnold, Michael Dunn, Gilbert Omenn, Matthew Potter, David Bartel, Arthur Beaudet, George Church
Lyle Arnold, Michael Dunn join Biocept management team; HTG appoints John Lubniewski as chief business officer; Ora Hirsch Pescovitz joins Life Tech's board
The company's first test, a FISH-based assay targeting breast cancer, is planned for October and would represent its first product introduction in its 13-year history.
Rosetta Genomics, Hitachi, Biocept, Brigham and Women's Hospital, Tufts University
A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.
A new analysis finds some cancers receive more nonprofit dollars than others.
An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.
In Science this week: comparative analysis of sex differences in mammal gene expression, and more.